Product Name :
PHT-427
CAS No.:
1191951-57-1
Purity :
> 98%
Shipping:
Shipped on dry ice.
Storage :
Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month
SMILES:
CCCCCCCCCCCCC1=CC=C(C=C1)[S](=O)(=O)NC2=NN=CS2
Product Description :
PHT-427 is a dual Akt and PDPK1 inhibitor (high affinity binding for the PH domains of Akt and PDPK1) with Ki of 2.7 μM and 5.2 μM, respectively.
Formula:
C20H31N3O2S2
Molecular Weight :
409.61
Synonyms:
CS-0223
Additional Information:
|CAS No. 1191951-57-1 ; |Synonyms CS-0223 ; |Formula C20H31N3O2S2 ; |Molecular Weight 409.61 ; |SMILES CCCCCCCCCCCCC1=CC=C(C=C1)[S](=O)(=O)NC2=NN=CS2 ; |Product Description PHT-427 is a dual Akt and PDPK1 inhibitor (high affinity binding for the PH domains of Akt and PDPK1) with Ki of 2.{{Bremelanotide} web|{Bremelanotide} Melanocortin Receptor|{Bremelanotide} Purity & Documentation|{Bremelanotide} In Vitro|{Bremelanotide} manufacturer|{Bremelanotide} Autophagy} 7 μM and 5.{{Spartalizumab} MedChemExpress|{Spartalizumab} PD-1/PD-L1|{Spartalizumab} Technical Information|{Spartalizumab} Description|{Spartalizumab} supplier|{Spartalizumab} Epigenetics} 2 μM, respectively.PMID:23775868 ; |Purity > 98% ; |Shipping Shipped on dry ice. ; |Storage Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month ; |Solubility Overview Soluble in DMSO